000 01677 a2200433 4500
005 20250516132737.0
264 0 _c20130419
008 201304s 0 0 eng d
022 _a1439-099X
024 7 _a10.1007/s00066-012-0273-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLangenbacher, M
245 0 0 _aIn vitro hypoxic cytotoxicity and hypoxic radiosensitization. Efficacy of the novel 2-nitroimidazole N,N,N-tris[2-(2-nitro-1H-imidazol-1-yl)ethyl]amine.
_h[electronic resource]
260 _bStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
_cMar 2013
300 _a246-54 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Hypoxia
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEthylamines
_xpharmacology
650 0 4 _aFlow Cytometry
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aJurkat Cells
650 0 4 _aMitochondria
_xdrug effects
650 0 4 _aNitroimidazoles
_xpharmacology
650 0 4 _aRadiation-Sensitizing Agents
_xpharmacology
650 0 4 _aReactive Oxygen Species
650 0 4 _aTumor Stem Cell Assay
700 1 _aAbdel-Jalil, R J
700 1 _aVoelter, W
700 1 _aWeinmann, M
700 1 _aHuber, S M
773 0 _tStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
_gvol. 189
_gno. 3
_gp. 246-54
856 4 0 _uhttps://doi.org/10.1007/s00066-012-0273-2
_zAvailable from publisher's website
999 _c22458532
_d22458532